Amesite Inc., an artificial intelligence driven platform and course designer, provides online products and services in the United States. It serves businesses, universities and colleges, and K-12 schools. The company is headquartered in Detroit, Michigan.
IPO Year: 2020
Exchange: NASDAQ
Website: amesite.com
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
4 - Amesite Inc. (0001807166) (Issuer)
DEFA14A - Amesite Inc. (0001807166) (Filer)
DEF 14A - Amesite Inc. (0001807166) (Filer)
EFFECT - Amesite Inc. (0001807166) (Filer)
S-1/A - Amesite Inc. (0001807166) (Filer)
8-K - Amesite Inc. (0001807166) (Filer)
10-Q - Amesite Inc. (0001807166) (Filer)
NT 10-Q - Amesite Inc. (0001807166) (Filer)
S-1 - Amesite Inc. (0001807166) (Filer)
SCHEDULE 13G - Amesite Inc. (0001807166) (Subject)
8-K - Amesite Inc. (0001807166) (Filer)
Fastest customizable press release news feed in the world
DETROIT, May 18, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), developer of the AI-native NurseMagic™ documentation platform and EMR for non-acute care, today announced it has secured a new enterprise customer representing an approximately 2,700-patient census—its largest deployment to date and a major milestone in validating its enterprise strategy. The customer will deploy NurseMagic™ AI documentation across its workforce to streamline workflows, integrate their EMR, and integrate with their electronic visit verification (EVV) workflow. The deployment is expected to significantly reduce the administrative burden that currently consumes up to 16 hours1 per caregiver per week. Thi
DETROIT, April 28, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the Company issued to the investors unregistered Series A-1 warrants to purchase up to 696,866 shares of common stock and unregistered Series A-2 warrants to purchase up to 696,866 shares of common stock. The warrants have an exercise price of $
DETROIT, April 28, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D, its Chairman and CEO, and George Parmer, a member of its board of directors, for the purchase and sale of an aggregate of 418,118 shares of its common stock, Series A-1 warrants to purchase an aggregate up to 418,118 shares of the Company's common stock and Series A-2 warrants to purchase an aggregate up to 418,118 shares of the Company's common stock at a purchase price of $1.435 per share and accompa
DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the Company has agreed to issue to the investor unregistered Series A-1 warrants to purchase up to 696,866 shares of common stock and unregistered Series A-2 warrants to purchase up to 696,866 shares of common stock. The warrants will have an exercise price of $1.435 per share and will be exerci
DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST) (the "Company"), a leading developer of AI-powered enterprise solutions, today announced that it has filed with the U.S. Securities and Exchange Commission (the "SEC") a request for withdrawal of the Company's Registration Statement on Form S-1 (No. 333-295187) originally filed on April 20, 2026 (the "Registration Statement"), as the Company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the public offering described in the Registration Statement. This
DETROIT, March 26, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into an Electronic Transactions Trading Partner Agreement with a leading homecare technology platform company, that processes tens of billions of dollars in homecare services annually. The Agreement establishes Amesite as a compliant trading partner, in accordance with HIPAA and applicable regulations. Under the Agreement, Amesite is authorized to securely connect NurseMagic™ to a leading electronic transaction infrastructure as a healthcare data submitter. This integration allows NurseMagic™ to streamline c
DETROIT, March 04, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST) today announced that its AI-powered healthcare platform, NurseMagic™, has been named a finalist in Nurse.org's "Best of Nursing Awards" in the AI Nursing Tool category. The recognition from one of the largest online nursing communities comes less than two years after launch and as Amesite scales NurseMagic™ into the U.S. post-acute care market, which recent analyses estimate at roughly $460–510 billion in 2025 and project to reach more than $800 billion by 2035. Clinicians in post-acute care spend a significant share of their time on documentation and administrative tasks that are essential for reimbursement and compli
DETROIT, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST) today announced the launch of the NurseMagic™ EMR, marking a significant expansion of the Company's platform following a year of strong sequential revenue growth and enterprise traction. The AI-native, modular EMR extends NurseMagic™ from a point-of-care solution into core post-acute care infrastructure, supporting both coexistence with legacy systems and full system replacement. Amesite expects to begin onboarding EMR customers in January 2026. Amesite's revenue growth has occurred in clear step changes aligned with the rollout of progressively higher-value product tiers, progressing from Individual to Teams, Teams+, a
DETROIT, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), a leading developer of AI-powered enterprise solutions, announces a 69% QoQ increase in revenue even as it reduced its spending. Amesite also reported expanding its customer base and offerings to post-acute health businesses across the U.S. The Company described these results and its pathway to offer the first AI-powered electronic medical record (EMR) by 2026 in a shareholder update made available yesterday on its website. As part of the shareholder update, Amesite Founder & CEO, Dr. Ann Marie Sastry discussed: Summary of FY 2025 10-K and Q1 2026 10-Q: Financial performance was described in the context of methodical
DETROIT, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), a leading developer of AI-powered enterprise solutions, today announced 63% revenue growth for its NurseMagic™ platform following the launch of its census-based Enterprise subscription model on July 14, 2025. Enterprise sales have now surpassed B2C sales, reflecting rising demand from post-acute care providers seeking scalable, compliant technology designed to deliver full reimbursement rates. Amesite also announces the launch of its AI-powered automated form fill for required government forms. "We're no longer just selling to employees – we're selling to serve every patient in the system and help organizations leve
Live finance-specific insights
DETROIT, Aug. 24, 2021 /PRNewswire/ -- Amesite Inc., (NASDAQ:AMST), an artificial intelligence software company providing advanced A.I. powered online learning ecosystems for business and higher education, announced today that it was selected by Michigan Works! Southeast to provide state-of-the-art workforce training to their team members. Michigan Works! Southeast is part of a sixteen-agency system. The Michigan Works! Association is a critical collective that "influences, educates and inspires actions that keeps Michigan working." The members of the association offer training, education, business development and access to employment opportunities. Michigan Works! Southeast serves nearly
Live Leadership Updates
DETROIT, June 20, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced the availability of its NurseMagicTM app to the public in late April, inviting users to join a gated waitlist of vetted users. On June 5, Amesite fully opened access to the app to the public. Within a week, nearly 1,200 individuals completed an onboarding survey, and registered as users of NurseMagicTM. CEO Dr. Ann Marie Sastry said, "This is the fastest growth in usership that we have ever seen with any of our products. We've been thrilled with the response from nurses, and fortun